US 2026/0174718 A1Published application

MODULATORS OF mTORC1 ACTIVITY AND USES THEREOF

AssigneeNavitor Pharmaceuticals, Inc.

InventorEddine Saiah

Life of this patent

Estimating the term…

The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.

Dependent claims

A compound having the formula LiCl*compound I, or a solvate or hydrate thereof, wherein compound I has the structure:

Dependencies are inferred from the claim text.

A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…
C07C 229/20
The carbon skeleton being acyclic and saturated: the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/141
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles: intimate…

From the US filing history. Foreign family members aren’t listed.

Loading patent…